These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 10962236)
1. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH Eur J Pharm Biopharm; 2000 Sep; 50(2):257-62. PubMed ID: 10962236 [TBL] [Abstract][Full Text] [Related]
2. Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH J Microencapsul; 2000; 17(3):343-62. PubMed ID: 10819422 [TBL] [Abstract][Full Text] [Related]
3. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process. Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241 [TBL] [Abstract][Full Text] [Related]
5. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Cleland JL; Jones AJ Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836 [TBL] [Abstract][Full Text] [Related]
6. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441 [TBL] [Abstract][Full Text] [Related]
7. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin. Cho SW; Song SH; Choi YW Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588 [TBL] [Abstract][Full Text] [Related]
8. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321 [TBL] [Abstract][Full Text] [Related]
9. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Lavelle EC; Yeh MK; Coombes AG; Davis SS Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157 [TBL] [Abstract][Full Text] [Related]
10. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells. Kavas A; Keskin D; Altunbaş K; Tezcaner A Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363 [TBL] [Abstract][Full Text] [Related]
11. Comparison of various injectable protein-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices: in-situ-formed implant versus in-situ-formed microspheres versus isolated microspheres. Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH Pharm Dev Technol; 2000; 5(2):201-7. PubMed ID: 10810750 [TBL] [Abstract][Full Text] [Related]
13. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Ravivarapu HB; Burton K; DeLuca PP Eur J Pharm Biopharm; 2000 Sep; 50(2):263-70. PubMed ID: 10962237 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres. Kostanski JW; Thanoo BC; DeLuca PP Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259 [TBL] [Abstract][Full Text] [Related]
15. Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. Morita T; Sakamura Y; Horikiri Y; Suzuki T; Yoshino H J Control Release; 2000 Dec; 69(3):435-44. PubMed ID: 11102683 [TBL] [Abstract][Full Text] [Related]
16. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. Morlock M; Kissel T; Li YX; Koll H; Winter G J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434 [TBL] [Abstract][Full Text] [Related]
17. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228 [TBL] [Abstract][Full Text] [Related]
18. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization. Chen W; Lu DR J Microencapsul; 1999; 16(5):551-63. PubMed ID: 10499836 [TBL] [Abstract][Full Text] [Related]